Tri-Valley Corp. (TIV) Video Chart for Wednesday, September 8, 2010
TIV is once again trying to form a base. While it has done this in the past and slipped through…
Blog
Oragenics, Inc. (ORNI.OB) Announces Availability of EvoraPlus® Oral Care Probiotics in Nationwide GNC Stores
Oragenics, Inc., a Florida-based biopharmaceutical company focused primarily on oral health products and novel antibiotics, recently announced that its oral…
Bond Laboratories’ (BNLB.OB) Resurrection Anti-Hangover Drink a Hit During the Attica 2 Year Anniversary Party
Bond Laboratories, Inc. issued a press release to detail the success of its “Resurrection Anti-Hangover” drink (“REZ”) as it was…
GelTech Solutions Inc. (GLTC.OB) Signs $5M Purchase Agreement with Lincoln Park Capital Fund
GelTech, www.GelTechSolutions.com – a company that helps save water while revolutionizing firefighting with products like the patent pending FireIce® fire…
CentraCan, Inc. (CTCJ.OB) Subsidiary Partners with Choice Hotels to Offer Green Battery Solution
CentraCan, a holding company with subsidiaries/JVs focused on sustainable solutions and eco-conscious products like the recyclable alkaline batteries offered through…
Helix Wind Corp. (HELX.OB) Receives Purchase Order for S594 Wind Turbines
Helix Wind Corp. is a global renewal energy company engaged in the design, manufacture and sales of small wind vertical…
NeoStem (NBS) Appoints Seasoned President and Managing Director
NeoStem Inc. develops stem cell-based therapies and has built a network of adult stem cell collection centers in the U.S.…
Micro Identification Technologies, Inc. (MMTC.OB) Offers Best Solution to Major Problem
If ever there was a company that has lived up to the old business adage “Find a good solution to…
China Direct Industries, Inc. (CDII) Video Chart for Tuesday, September 7, 2010
CDII is forming a base at $.94 and appears to be trying to make a move north. While the indicators…
Rexahn Pharmaceuticals (RNN) Submits Phase IIb Protocol to FDA for Major Depressive Disorder Treatment
Rexahn Pharmaceuticals Inc., a clinical stage company focused on developing and commercializing oncology and CNS therapeutics, has submitted a phase…